Utama › Kanser Metastatik › Utah › Salt Lake City
Kajian klinikal Kanser Metastatik di Salt Lake City, UT
20 kajian untuk Kanser Metastatik sedang mencari peserta di lokasi dalam dan sekitar Salt Lake City (dalam lingkungan kira-kira 30 batu). Buka kajian untuk melihat siapa yang layak menyertai dan cara menghubungi pasukan kajian.
Teks kajian rasmi (Bahasa Inggeris)
Mengambil peserta untuk kajian di sini? Paparkan di bahagian atas halaman ini — $99 selama 30 hari →
A Study of LY4052031 in Participants With Advanced or Metastatic Urothelial Cancer or Other Solid Tumors
Mengambil pesertaFasa 1
- University of Utah - Huntsman Cancer Institute, Salt Lake City
A Study With NKT3964 for Adults With Advanced/Metastatic Solid Tumors
Mengambil pesertaFasa 1
- Intermountain Health, Salt Lake City
Zanzalintinib Versus Everolimus in Participants With Locally Advanced or Metastatic Neuroendocrine Tumors
Mengambil pesertaFasa 2/3
- Huntsman Cancer Institute, University of Utah, Salt Lake City
First-in-Human Study of DS-3939a in Participants With Advanced Solid Tumors
Mengambil pesertaFasa 1/2
- Huntsman Cancer Institute, University of Utah, Salt Lake City
Symbiotic-Lung-01 : A Study to Learn About the Study Medicine Called PF-08634404 in Combination With Chemotherapy in Adult Participants With Locally Advanced or Metastatic Non-Small Cell Lung Cancer
Mengambil pesertaFasa 3
- Huntsman Cancer Institute, University of Utah, Salt Lake City
A Three-Part Phase 3 Study of Sofetabart Mipitecan in Participants With Platinum-Resistant (Part A) and Platinum-Sensitive (Parts B and C) Ovarian Cancer
Mengambil pesertaFasa 3
- Huntsman Cancer Institute, Salt Lake City
A Study of Tersolisib (LY4064809/STX-478) With Other Anti-Cancer Treatments in Participants With Advanced Breast Cancer With a Genetic Change (PIK3CA)
Mengambil pesertaFasa 3
- Utah Cancer Specialists, Salt Lake City
Study of AU-007, A Monoclonal Antibody That Binds to IL-2 and Inhibits IL-2Rα Binding, in Patients With Unresectable Locally Advanced or Metastatic Cancer
Mengambil pesertaFasa 1/2
- University of Utah - Huntsman Cancer Institute, Salt Lake City
FORAGER-1: A Study of Vepugratinib (LY3866288; LOXO-435) in Participants With Cancer With a Change in a Gene Called FGFR3
Mengambil pesertaFasa 1
- University of Utah, Salt Lake City
Studying the Safety and Determining the Optimal Dose of Novobiocin in Patients With Tumors That Have Alterations in DNA Repair Genes
Mengambil pesertaFasa 1
- Huntsman Cancer Institute/University of Utah, Salt Lake City
A Study to Investigate Safety and Effectiveness of CRN09682 in Participants With SST2-Expressing NENs and Other Solid Tumors
Mengambil pesertaFasa 1/2
- Crinetics Study Site, Salt Lake City
A Study of ART0380 for the Treatment of Advanced or Metastatic Solid Tumors
Mengambil pesertaFasa 1/2
- Utah Cancer Specialists, Salt Lake City
A Study of CHS-114 (Tagmokitug) in Combination With Toripalimab and/or Other Treatments in Participants With Advanced Solid Tumors
Mengambil pesertaFasa 1
- Huntsman Cancer Institute, University of Utah, Salt Lake City
A Phase 1 Dose-escalation Trial of KST-6051 in Participants With Advanced Solid Tumors With Kirsten Rat Sarcoma Viral Oncogene Homolog (KRAS) Mutation
Mengambil pesertaFasa 1
- Huntsman Cancer Institute, University of Utah, Salt Lake City
BBO-11818 in Adult Subjects With KRAS Mutant Cancer
Mengambil pesertaFasa 1
- Huntsman Cancer Institute, Salt Lake City
Study of RMC-6236 in Patients With Advanced Solid Tumors Harboring Specific Mutations in RAS
Mengambil pesertaFasa 1/2
- Huntsman Cancer Institute, Salt Lake City
A Phase 1/2 Study of VS-7375 in Patients With KRAS G12D-Mutated Solid Tumors
Mengambil pesertaFasa 1/2
- Huntsman Cancer Institute, Salt Lake City
Topical Tretinoin Prophylaxis for Anti-EGFR Induced Skin Toxicity in Patients With Solid Tumors
Mengambil pesertaFasa 2
- Huntsman Cancer Institute at University of Utah, Salt Lake City
VMD-928 Monotherapy and in Combination With Pembrolizumab to Treat TrkA Overexpression Driven Solid Tumors or Lymphoma
Mengambil pesertaFasa 1/2
- Utah Cancer Specialists (site 203), Salt Lake City
SYNERGY-AI: Artificial Intelligence Based Precision Oncology Clinical Trial Matching and Registry
Mengambil pesertaKajian pemerhatian
- Massive Bio SYNERGY-AI site, Salt Lake City
Kajian Kanser Metastatik di bandar lain
- Houston, TX104 kajian
- New York City, NY93 kajian
- Nashville, TN70 kajian
- Boston, MA63 kajian
- Los Angeles, CA57 kajian
- St. Louis, MO54 kajian
- Arlington, VA53 kajian
- Philadelphia, PA46 kajian
- Chicago, IL45 kajian
- San Antonio, TX44 kajian
- Washington, DC43 kajian
- Dallas, TX42 kajian
Kajian lain di Salt Lake City
- Kanser Paru-paru Bukan Sel Kecil31 kajian
- Kanser (semua jenis)27 kajian
- Kanser Payudara27 kajian
- Kanser Kolorektal22 kajian
- Kanser Paru-paru21 kajian
- Melanoma21 kajian
- Mieloma Pelbagai21 kajian
- Kanser Ovari19 kajian
- Obesiti18 kajian
- Leukemia Mieloid Akut17 kajian
- Kegagalan Jantung17 kajian
- Kanser Prostat15 kajian
Daripada ClinicalTrials.gov, data diperoleh pada 6 Okt 2026. Setiap kajian menetapkan kriteria kelayakannya sendiri; pasukan kajian menentukan siapa yang layak menyertai.